Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis. - Wikidata - awgldk - TriplyDB

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

http://www.wikidata.org/entity/Q37394390

about

The Modulation of Apoptotic Pathways by Gammaherpesviruses Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice Epstein-Barr virus latent genes Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A Rapamycin reverses splenomegaly and inhibits tumor development in a transgenic model of Epstein-Barr virus-related Burkitt's lymphoma.A shared gene expression signature in mouse models of EBV-associated and non-EBV-associated Burkitt lymphoma Dasatinib therapy results in decreased B cell proliferation, splenomegaly, and tumor growth in a murine model of lymphoma expressing Myc and Epstein-Barr virus LMP2A.Epstein-Barr virus Latent Membrane Protein 2A (LMP2A)-mediated changes in Fas expression and Fas-dependent apoptosis: Role of Lyn/Syk activation.Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.Frequency of Epstein Barr Virus Type 1 Among Nasopharyngeal Carcinomas in Iranian Patients The cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuli Epstein-Barr virus interactions with the Bcl-2 protein family and apoptosis in human tumor cells.Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma.MYC-associated and double-hit lymphomas: a review of pathobiology, prognosis, and therapeutic approaches.Mouse model of Epstein-Barr virus LMP1- and LMP2A-driven germinal center B-cell lymphoproliferative disease.Latent Membrane Protein 1 (LMP1) and LMP2A Collaborate To Promote Epstein-Barr Virus-Induced B Cell Lymphomas in a Cord Blood-Humanized Mouse Model but Are Not Essential.EBV germinates lymphoma from the germinal center in a battle with T and NK cells.EBV and Apoptosis: The Viral Master Regulator of Cell Fate?EBV latent membrane protein 2A orchestrates p27kip1 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.Spleen Tyrosine Kinase Inhibitor TAK-659 Prevents Splenomegaly and Tumor Development in a Murine Model of Epstein-Barr Virus-Associated Lymphoma

P2860

Q26747452-55B0D3D5-93FC-4A77-B431-2C88B70E1EC1 Q27345929-C39275F1-EC6E-4AA7-856B-F61C9568EB6D Q28082701-33168227-C1DB-496D-8F6A-DAB2446CF0FA Q33794029-7F55DBB3-FF9C-42AD-ADDB-4FBAE7693369 Q34774645-35CB4C46-8600-4515-9E71-A992C98DE366 Q35631310-DF17739D-CC1D-487F-B0E3-4A2554B73C9B Q36040966-0567DCAB-64E7-47DC-8A5E-F5F997D9DDE5 Q36199894-EB7D64BA-4ACD-4581-8514-4B1EA50DB4CB Q36246412-BBFAA57A-7E1C-4B04-8824-9AF6DA702070 Q36323473-DA37B96B-E931-40D3-A81B-56557448A659 Q36414572-923FDD74-E67E-43EA-B976-138FD04A2A20 Q36526103-D51A2B14-5335-41E4-A8C2-089DFC9E4B5E Q37512075-49BF1F01-4011-4740-AC74-CF8F2369EB9B Q38233772-E1B5E331-7AC2-48F0-902B-65511765B2F1 Q40269570-1D3110AB-D811-47DD-9464-CD5C3D04E547 Q40375799-3D65FF68-5B93-4F36-ABE6-8C89DB9FB279 Q43083592-74C5027E-75B3-4AA2-94D8-226993D9122B Q47117102-BBC5AD29-58AF-43CE-BD3C-45BA5533C687 Q47598522-345F1145-1C52-4736-85BA-1DB03E85E860 Q58721423-63F6974D-DEB8-4985-949C-92D267FE4197

P2860

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

http://www.wikidata.org/entity/Q37394390

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 07 October 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@en

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@nl

type

label

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@en

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@nl

prefLabel

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@en

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@nl

P1433

Q37394390-45597304-7A9E-4AE5-AD04-00FDB59ED7DF

P1476

Q37394390-A0AD7B2E-9575-4EEB-866E-A8517D3D1C99

P2093

Q37394390-67F27BC6-F922-43C3-93B1-C1F51D4E9D46

Q37394390-6E1F5AD0-E512-486C-8A60-9980DD9FD098

Q37394390-A229AC2E-7C92-49EF-BA6A-0CC94117F554

P2860

Q37394390-00FDE06C-4532-4643-AE69-5AF94BF057C6

Q37394390-087B56BE-29AE-4358-9A26-5587B678534A

Q37394390-199756EE-4449-4025-B21E-05F97D2A4BDF

Q37394390-19BBDE75-E578-4C4C-822D-0F6AA1AB25CD

Q37394390-1A5BCCE3-6CE7-48A6-8CED-57B8218204EA

Q37394390-2122E9A1-8883-47E6-8AF5-8196843EB6D9

Q37394390-29C8A082-C7DE-4F2C-8DA7-590E419EF11A

Q37394390-2A7BDE90-DF8B-4D54-BE3E-D4BF23678F32

Q37394390-334E81B0-A929-48AE-BEBF-9B2CED5B31C3

Q37394390-34B97B49-0AD2-45B4-BDE6-7006FDFB651A

P304

Q37394390-0FBB7356-504C-4887-B5BB-0507A6B7D663

P31

Q37394390-E349F8ED-CDF6-45BC-910F-6C72240FEF53

P356

Q37394390-10280146-D52F-4F73-9675-EBCCAB249636

P407

Q37394390-E58897D3-01A6-4247-AB80-8B5E7D427168

P433

Q37394390-CFD9AD6B-F1D7-4DED-9383-7D122AB9ABB2

P478

Q37394390-A0E019D2-4555-4EA0-B81C-1AC9C3C86A4F

P577

Q37394390-BAD31FC7-9748-4F2D-B318-AE98D8E082FF

P5875

Q37394390-93D5BF58-4231-4B49-BCBF-DE9561215198

P698

Q37394390-82CA94CB-B545-4872-95FC-E1255DFC2452

P921

Q37394390-1901A0C3-41AD-44F5-BFC0-5B26D73EEB3C

P932

Q37394390-E1CE9D66-6B46-4883-81F1-2C62C21A5B3F

P356

PNAS.0907994106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Epstein-Barr virus LMP2A bypasses p53 inactivation in a MYC model of lymphomagenesis.

@en

P2093

Alexandra C Amick

http://www.w3.org/2001/XMLSchema#string

Kathryn T Bieging

http://www.w3.org/2001/XMLSchema#string

Richard Longnecker

http://www.w3.org/2001/XMLSchema#string

P2860

Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2

c-MYC: more than just a matter of life and death

Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.

Epstein-Barr virus LMP2A alters in vivo and in vitro models of B-cell anergy, but not deletion, in response to autoantigen.

The c-Myc transactivation domain is a direct modulator of apoptotic versus proliferative signals.

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

P304

17945-17950

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0907994106

http://www.w3.org/2001/XMLSchema#string

P407

P433

42

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2009-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26881486

http://www.w3.org/2001/XMLSchema#string

P698

19815507

http://www.w3.org/2001/XMLSchema#string

P921

Epstein–Barr virus

P932

2764894

http://www.w3.org/2001/XMLSchema#string